Neither the completion of an intake nor the submission of any other information to this law firm constitutes the establishment of an attorney client relationship. No attorney client relationship will exist between you and Nadrich and Cohen, LLC without a specific written retainer agreement between you and this firm.
Transvaginal Mesh Attorney Los Angeles - Latest News
Latest News on Transvaginal Mesh
» April 7th, 2014 - There is much activity in the pelvic mesh sling arena scheduled for 2014
April 7th, 2014
There is much activity in the pelvic mesh sling arena scheduled for 2014
Thus far, tens of thousands of these cases have been filed in courts nationwide including in West Virginia, New Jersey, Massachusetts, Minnesota, Delaware, California and Georgia. The judges in these states have selected certain cases for bellwether trials – all scheduled for 2014. A bellwether trial means that the parties have decided that the particular case is representative of a certain type of defect and the case is chosen for a jury trial to assist the parties and the judge in evaluating the case and whether or not there is a judgment valuing the amount of judgment for future settlement purposes for larger groups of similar cases.
Our law firms are involved in many of the upcoming bellwether trials including the five trials against Boston Scientific scheduled in Massachusetts, the trial scheduled against Ethicon in New Jersey and the trial scheduled against Ethicon in West Virginia Federal Court. There are also 200 trials currently scheduled against C.R. Bard in West Virginia Federal Court beginning in May 2014. Our co-counsel also has trials against American Medical Systems in West Virginia.
» February 28th, 2013 - $3.35 million vaginal mesh verdict against Johnson & Johnson.
February 28th, 2013
$3.35 million vaginal mesh verdict against Johnson & Johnson.
The jury has decided.
A state court in New Jersey jury gave a vaginal mesh victim a verdict against Johnson & Johnson for $3.35 million. This, after a three week jury trial. On February 28th the jury came back and awarded the plaintiff an additional $7.76 million in punitive damages because Johnson & Johnson knew beforehand of the dangers of the vaginal mesh implanted in women but did not sufficiently warn of the problems.
The plaintiff is a 47 year-old woman who had a Johnson & Johnson Ethicon device implanted for pelvic organ prolapse. Within months she began experiencing significant side effects including recurring prolapse, perforation of the bladder, intestines and uterus. Sadly, she had to have multiple surgeries to have the mesh surgically trimmed and / or removed. Often times removal can take multiple surgeries. She had to have 18 operations to repair the damage caused by the mesh.
It is important to note that public alerts about Vaginal Mesh problems issued by the FDA are now five years old.
In June 2012 Johnson & Johnson’s Ethicon unit stopped selling its mesh products but did not officially recall the products.
Our law firm and our partners have over 8,000 Vaginal Mesh clients who have suffered because of vaginal mesh sling implants.
If you have experienced any kind of injury after your vaginal mesh procedure please contact one of our specialists at Contact Us Online.
If you are not sure you want to make a claim please call us and we will let you know if you have a claim.
» October 5, 2012 - Atrium C-QUR Mesh Side Effects
October 5, 2012 - Atrium C-QUR Mesh Side Effects
Nadrich & Cohen, experienced national pharmaceutical medical device and products defects law firm, are representing victims of the Atrium C-QUR mesh.
If you or your loved one suffered the above injuries from the Atrium C-QUR mesh you have a right to financial recovery. The national products defect medical device law firm of Nadrich & Cohen has been handling lawsuits for surgical mesh victims for many years. We are already involved in over 14 different various surgical mesh defective product lawsuits.
Click here to read more »
» October 5, 2012 - Transvaginal Mesh Verdict in Bakersfield, California.
October 5, 2012 - Transvaginal Mesh Verdict in Bakersfield, California.
Recently, there was a vaginal mesh trial which ended in a $5.5 million verdict for the victim.
There are approximately 1,100 cases in the multi-district federal West Virginia court against CR Bard, Boston Scientific, Johnson & Johnson subsidiary Ethicon and American Medical Systems.
Total number of cases thus far filed is approximately 3,500.
Most of our clients (we have over 500 cases) have suffered tremendous pain and problems due to the vaginal mesh implant including punctures, migration, erosion, protrusion into the vagina, chronic pain and difficulties with sex.
In the last few months Johnson & Johnson withdrew its vaginal mesh products from the market.
Nadrich & Cohen is a national products device law firm handling medical device cases including vaginal mesh victims' cases in all 50 states. You may contact us at email@example.com.
» October 5, 2012 - Nadrich & Cohen announces the filing of an Actos bladder cancer case against Actos manufacturer Takeda and Eli Lilly.
October 5, 2012
Nadrich & Cohen announces the filing of an Actos bladder cancer case with its national team of lawyers against Actos manufacturer Takeda and Eli Lilly. Our client died as a result of using the diabetes drug known as Actos.
The suit which filed in California alleges that our anonymous client was diagnosed with bladder cancer after taking Actos for a number of years to treat type two diabetes. We believe that Takeda and Eli Lilly withheld valuable information that they knew that Actos can cause bladder cancer. Our lawsuit seeks a financial recovery for our client including death benefits, pain and suffering, medical expenses, economic losses and attorney's fees.
If you or a loved one suffered bladder cancer from Actos contact a specialist today at the national medical products law firm Nadrich & Cohen. Nadrich & Cohen handles medical device and pharmaceutical cases such as Actos in all 50 states.
» July 30, 2012 - Judge Orders Three Johnson & Johnson Executives to Testify
July 30th, 2012 - Judge Orders Three Johnson & Johnson Executives to Testify
A New Jersey judge ordered three Johnson & Johnson executives to testify in the New Jersey State Court Transvaginal Mesh lawsuits.
Currently, there are over 1000 mesh cases filed in New Jersey. The judge ordered Johnson & Johnson's Chief Executive Officer, its Vice Chairman and its Ethicon franchise leader to give their deposition concerning their involvement in Transvaginal Mesh marketing.
The judge also ruled that the executives' computers can be searched for relevant documents. Ethicon is a subsidiary of Johnson & Johnson and the manufacturer of multiple transvaginal mesh devices including Prolift, Prolift Plus M, Prosima, and DVT Secur.
In June 2012 Johnson & Johnson withdrew these four transvaginal mesh products from the marketplace. Johnson & Johnson, although withdrawing the products, stated this was not a product recall.
» July 25th, 2012 - Transvaginal Mesh Products May Receive Yet Another Federal Multidistrict Litigation
July 25th, 2012 - Transvaginal Mesh Products May Receive Yet Another Federal Multidistrict Litigation
There are five current Federal Multidistrict Litigations involving the Transvaginal Mesh Patch / Sling. Although there are already five, a sixth is being considered.
The sixth would be a multi-district litigation which consolidates all pretrial discovery for each individual injury case which is joined as a group against the same manufacturer for the same product. That means that all the lawyers will share evidence and testimony. Once this process is completed individual trials can occur.
This is different from a class action lawsuit because each plaintiff in multi district litigation will have their own trial and separate settlement.
The judges are considering a sixth Multi District Litigation involving mesh products made by Mentor and sold by Coloplast. Thus far, approximately 24 cases have been filed. The new MDL may be located in Charleston, West Virginia.
There are currently four MDLs in West Virginia including Bard – Avaulta, Ethicon, Inc., American Medical Systems, Inc., and Boston Scientific.
The fifth, involving Mentor AB Tape is in Georgia.
» July 24, 2012 - 1st California Transvaginal Mesh Trial / $5.5 Million Verdict
July 24, 2012 - Transvaginal Mesh Litigation: 1st Of Its Kind Verdict Reached Today
Christine Scott, is a 53 year old Bakersfield, California woman; a former runner who had undergone a transvaginal mesh implant procedure as a means to treat her stress urinary incontinence in 2008. After implantation, Scott's overall wellbeing went downhill as the mesh eroded into her colon. Yesterday, Monday July 23, 2012, Scott won her case against Bard, being awarded $5.5 million in the lawsuit she had filed against the company. The jury found that the product stated to help correct urinary leakage had injured her. The Avaulta Plus Biosynthetic Support System, designed by Bard had left her with incontinence, in chronic pain, and unable to enjoy relations with her husband. Along with these complications Scott faces many surgeries to correct the problems caused by the mesh. In an interview with KGET-TV 17, Scott had imparted that "I don't know if I'll have one or one hundred surgeries ahead".
The Bard company, formerly known as C.R. Bard, has been indicted in a settlement regarding its transvaginal mesh device that many women who suffer stress urinary incontinence resort to implanting through their reproductive organs. It is worth noting that this procedure has single-incision mini-slings implanted for women who opt for it. Transvaginal mesh is also used for vaginal repair of a female patient's pelvic organ prolapse.
According to the latest press wire by the FDA on May 17, 2012, the FDA had ordered manufacturers and producers of transvaginal mesh to conduct postmarket surveillance studies that had reached a cumulative total of 522. As litigation against manufacturers of the device gains traction, many women are coming forward with their complaints regarding settling their grievances in the legal realm and people in the medical industry as well as the legal establishment are starting to take notice.
Author: Partha Choudhury
Click here to read the entire article
» June 4, 2012 - News Update
June 4th, 2012
Medical device manufacturer Johnson & Johnson announced in Federal Court on June 4th that it would cease "commercializing" and selling its Ethicon products including the Gynecare TVT Secur system, Gynecare Profima Repair System, Gynecare Prolift Pelvic and Gynecare Prolift. Ethicon will now be only implanting these devices through the abdomen rather than vaginally because, as we have always argued, when these products are implanted transvaginally they are unsafe and often cause horrific side effects.
Johnson & Johnson also announced a label change restricting the Gynemesh vaginal mesh implant from now on to only the abdominal sacrocolpopexy procedure for Pelvic Organ Prolapse treatment. What that means is the Gynemesh product will no longer be used for transvaginal surgeries and will only be inserted through an incision at the lower abdomen.
We applaud Johnson & Johnson for finally taking the necessary action concerning their Ethicon transvaginal mesh products. We only wish these actions occurred many years ago before the many thousands of women who suffered horrible side effects as a result of these products being implanted transvaginally.
Our lawyers serve on the Plaintiff's Steering Committee in the T.V.M.federal litigation and are liason counsel in the New Jersey State Court action and are on the Steering Committee in the West Virginia Federal litigation pending in the United States District Court Judge Joseph R. Goodwin presiding.
Our legal teams are filing lawsuits all over the country on behalf of victims injured by vaginal mesh products marketed and distributed by all T.V.M. manufacturers. We have thus far over 500 cases and are interviewing and investigating side effect victims claims daily. Call us today.
If you or a loved one suffered side effects from these products please contact one of our intake specialists. You can also fill out the Free Case Review on the right. We promise you we will be sensitive to your concerns. We understand what you're going through. We have 18 offices throughout California and are handling transvaginal mesh side effect victims claims in all 50 states.
» June 1, 2012 - Bard faces first federal trial in 2013
C.R. Bard Inc. will face its first federal trial in 2013 for its Vaginal Mesh Products.
Judge Goodwin in Charleston, West Virginia set a February 5th, 2013 trial date for the first of approximately 600 federal cases filed against the Bard transvaginal mesh device known as Avaulta.
Bard is based in Maryhill, New Jersey. It faces thousands of lawsuits throughout the United States due to its transvaginal mesh products.
More than 75,000 women a year have had implanted in them these transvaginal mesh products. These products are inserted vaginally to treat Pelvic Organ Prolapse or Stress Urinary Incontinence.
The FDA has previously publicly reported that vaginal mesh sling products bear a high risk to patients.
In January 2012 the FDA ordered all Transvaginal Mesh manufacturers to study the side effects of organ damage and other significant complications due to their products.
There are many mesh suits against Bard and Johnson & Johnson which have been filed in Atlantic City, New Jersey state court with Judge Carol Higbee coordinating all discovery. The first trial date on cases has been set for November 5th against the Ethicon subsidiary of Johnson & Johnson due to their Gyncare Prolift vaginal mesh system.
In February, 2012 the Judicial Federal Council of Judges for multidistrict litigation consolidated all federal suits against pelvic mesh manufacturers before Judge Goodwin in West Virginia. These include cases against Bard, Johnson & Johnson, Boston Scientific and American Medical Systems products including its Perigee, Apogee and Elevate surgical mesh models.
Nadrich & Cohen's national teams are part of the group of plaintiff's lawyers who will oversee the pretrial information exchange in the consolidated federal cases.
If you or a loved one suffered from any transvaginal mesh product contact our law firm today. We have thus far over 500 cases against all manufacturers.
» April 20, 2012 - News Update
April 20, 2012
Because of Nadrich & Cohen's extensive involvement with trans-vaginal mesh victims around the country including throughout the East Coast and New England we have been contacted by certain congressional offices who are preparing and working on legislation to correct the present 510k exemption process which is the basis that all trans vaginal mesh manufacturers used to obtain approval from the Federal Drug Administration to sell the polyurethane based mesh implants which have caused many thousands of women to suffer.
It is a testimony to the success, integrity and active involvement of Nadrich & Cohen throughout the country in trans Vaginal Mesh litigation in helping women who have suffered because of trans vaginal mesh that Congress has reached out to us for assistance, aid and resources to help with the new Vaginal Mesh legislation.
The Congressmen we are working with is Congressman Edward J. Markey of Massachusetts. The legislation is the proposed House of Representative Bill entitled "Defective Devices, Destroyed Lives, Loophole Leaves Patients Unprotected From Flawed Medical Devices" which the proposed draft can be read in its entirety by clicking here.
We want to thank members of Congress for allowing us to have input and assist in proposed legislation to make certain that the of the trans vaginal mesh sling tragedy will never happen again.